FILE PHOTO - Liam Condon, Bayer's global crop science Chief Executive Officer, attends a news conference in Sao Paulo, Brazil July 3, 2018. Bayer's head of crop science has said he is against creating any further splits in the company. Liam Condon told the Financial Times he failed to see how a proposal to divide the company into standalone healthcare and agriculture businesses would add any value to either branch. The move comes as Bayer faces pressure from other German companies over its handling of glyphosate, which it acquired for $66 billion last year.
Bayer's head of crop science has said he is against creating any further splits in the company. Liam Condon told the Financial Times he failed to see how a proposal to divide the company into standalone healthcare and agriculture businesses would add any value to either branch. The move comes as Bayer faces pressure from other German companies over its handling of glyphosate, which it acquired for $66 billion last year.